Inability to provide an informed consent
Evidence of oral distant metastasis or other malignancies
The patient has received prior surgery for primary tumor or lymph node ( except for biopsy )
Prior radiotherapy for primary tumor
The patient has previously received anti-tumor biological targeted therapy
The patient has received chemotherapy or immunotherapy for primary tumors
Prior malignancy within the previous 5 years (except for cured skin basal cell carcinoma or cervical carcinoma in situ)
With 3-4 grad Allergy to any drug in the treatment
Peripheral neuropathy> 1 grade
Any unstable systematic disease (including active infection, uncontrolled high blood pressure, unstable angina, onset of angina within the last 3 months, congestive heart failure, myocardial infarction within the previous 12 months, severe arrhythmia needing drug treatment, liver, kidney or metabolic disease)
HIV positive
Chronic diseases requiring immune agents or hormone therapy
Pregnant or lactating women
Drug/alcohol abuse, psychological or spiritual illness that may interfere compliance to the study
Patients with epilepsy requiring medications (such as steroids or antiepileptic drugs)
The patient has participated in other experimental therapy studies within 30 days
Researchers believe that the situation is unsuitable for participation in the group

NCT03017053_exc_T2
Qualifier
distant
NCT03017053_exc_T3
Qualifier
oral
NCT03017053_exc_T4
Condition
metastasis
NCT03017053_exc_T5
Qualifier
other
NCT03017053_exc_T6
Condition
malignancies
NCT03017053_exc_T7
Temporal
prior
NCT03017053_exc_T8
Procedure
surgery
NCT03017053_exc_T9
Qualifier
primary
NCT03017053_exc_T10
Condition
tumor
NCT03017053_exc_T11
Condition
lymph node
NCT03017053_exc_T12
Scope
tumor or lymph node
NCT03017053_exc_T13
Procedure
biopsy
NCT03017053_exc_T14
Negation
except for
NCT03017053_exc_T15
Scope
except for biopsy
NCT03017053_exc_T16
Procedure
radiotherapy
NCT03017053_exc_T17
Temporal
Prior
NCT03017053_exc_T18
Qualifier
primary
NCT03017053_exc_T19
Condition
tumor
NCT03017053_exc_T20
Procedure
anti-tumor biological targeted therapy
NCT03017053_exc_T21
Temporal
previously
NCT03017053_exc_T22
Procedure
chemotherapy
NCT03017053_exc_T23
Procedure
immunotherapy
NCT03017053_exc_T24
Condition
primary tumors
NCT03017053_exc_T25
Scope
chemotherapy or immunotherapy
NCT03017053_exc_T26
Condition
malignancy
NCT03017053_exc_T27
Temporal
Prior
NCT03017053_exc_T28
Temporal
within the previous 5 years
NCT03017053_exc_T29
Condition
cured skin basal cell carcinoma
NCT03017053_exc_T30
Condition
cervical carcinoma in situ
NCT03017053_exc_T31
Negation
except for
NCT03017053_exc_T32
Scope
cured skin basal cell carcinoma or cervical carcinoma in situ
NCT03017053_exc_T33
Qualifier
3-4 grad
NCT03017053_exc_T34
Condition
Allergy
NCT03017053_exc_T35
Drug
drug
NCT03017053_exc_T36
Qualifier
any
NCT03017053_exc_T37
Condition
Peripheral neuropathy
NCT03017053_exc_T38
Qualifier
> 1 grade
NCT03017053_exc_T39
Condition
systematic disease
NCT03017053_exc_T40
Qualifier
unstable
NCT03017053_exc_T41
Condition
infection
NCT03017053_exc_T42
Condition
high blood pressure
NCT03017053_exc_T43
Qualifier
uncontrolled
NCT03017053_exc_T44
Condition
unstable angina
NCT03017053_exc_T45
Temporal
within the last 3 months
NCT03017053_exc_T46
Measurement
onset
NCT03017053_exc_T47
Condition
angina
NCT03017053_exc_T48
Condition
congestive heart failure
NCT03017053_exc_T49
Condition
myocardial infarction
NCT03017053_exc_T50
Temporal
within the previous 12 months
NCT03017053_exc_T51
Qualifier
severe
NCT03017053_exc_T52
Condition
arrhythmia
NCT03017053_exc_T53
Drug
drug
NCT03017053_exc_T54
Procedure
treatment
NCT03017053_exc_T55
Condition
metabolic disease
NCT03017053_exc_T56
Condition
 meta HIV pos
NCT03017053_exc_T57
Condition
dney HIV pos
NCT03017053_exc_T58
Scope
infection, uncontrolled high blood pressure, unstable angina, onset of angina within the last 3 months, congestive heart failure, myocardial infarction within the previous 12 months, severe arrhythmia needing drug treatment, liver, kidney or metabolic disease
NCT03017053_exc_T59
Scope
unstable systematic disease
NCT03017053_exc_T60
Condition
HIV positive
NCT03017053_exc_T61
Condition
Chronic diseases
NCT03017053_exc_T62
Drug
immune agents
NCT03017053_exc_T63
Procedure
hormone therapy
NCT03017053_exc_T64
Scope
immune agents or hormone therapy
NCT03017053_exc_T65
Condition
Pregnant
NCT03017053_exc_T66
Condition
lactating
NCT03017053_exc_T67
Person
women
NCT03017053_exc_T69
Condition
epilepsy
NCT03017053_exc_T70
Drug
medications
NCT03017053_exc_T71
Drug
steroids
NCT03017053_exc_T72
Drug
antiepileptic drugs
NCT03017053_exc_T73
Scope
steroids or antiepileptic drugs